Healthcare Providers and Services
Company Overview of Cancer Treatment Centers of America, Inc.
Cancer Treatment Centers of America, Inc. owns and operates cancer care hospitals. It offers medical oncology, surgical oncology, radiation oncology, hematologic oncology, and neurosurgery services; nutrition therapy, pain management, naturopathic medicine, mind-body medicine, oncology rehabilitation, and spiritual support; care management, patient relations, culinary services, outpatient accommodations, transportation, and activities and classes services; acupuncture, chiropractic care, survivorship support, patient education, pharmacy, and HCAHPS comparison services; and interventional pulmonology, gastroenterology, and interventional radiology services. Cancer Treatment Centers of America...
1336 Basswood Road
Schaumburg, IL 60173
Founded in 1988
Key Executives for Cancer Treatment Centers of America, Inc.
Chief Executive Officer and President
Founder and Chairman of the Board
Chief Medical Information Officer, Senior Vice President of Information Services and Naturopathic Physician
Chief Executive Officer of Eastern Regional Medical Center and President of Eastern Regional Medical Center
Compensation as of Fiscal Year 2014.
Cancer Treatment Centers of America, Inc. Key Developments
Cancer Treatment Centers of America Launches Clinical Trial Combining Chemotherapy and Immunotherapy
Jan 14 15
Cancer Treatment Centers of America (CTCA) at Western Regional Medical Center (Western) in Goodyear, Arizona is now accepting patients into a clinical trial that combines more traditional chemotherapy drugs (gemcitabine, docetaxel, nab-paclitaxel, vinorelbine, irinotecan, and/or liposomal doxorubicin) with immunotherapy (pembrolizumab), activating the body’s own immune system to improve upon results that may be achieved from chemotherapy alone. Uniquely, the PembroPlus Phase Ib and Phase II study will target patients with advanced metastatic sarcoma, small cell lung cancer, and pancreatic adenocarcinoma. There are anticipated to be up to 140 patients enrolled on this multi-arm study. Recent data reported in the New England Journal of Medicine1 and Lancet2 demonstrates promising results with antibody-based immunostimulatory therapy in treating melanoma, renal cell carcinoma, and non-small cell lung cancer. Data has also shown synergetic effects of utilizing cytotoxic chemotherapy in combination with immunostimulatory therapy. PembroPlus will build upon this data, extending treatment options to additional cancer types.
Cancer Treatment Centers of America Names Nancy Hesse as its Chief Nursing Officer
Nov 10 14
Cancer Treatment Centers of America has named Nancy Hesse, MSN, RN, as its Chief Nursing Officer. Hesse previously held the position of SVP, Patient of Care Services at CTCA - Eastern Regional Medical Center and will continue in that role while assuming her new position. In this position, Hesse will be responsible for leading the development and execution of system-wide programs and best practices for safety outcomes and clinical quality. Utilizing her leadership skills, Hesse will be the voice of nursing for CTCA to ensure that the nursing staff is heard and accounted for in organizational decisions. Hesse joined CTCA in January 2014 after serving as Chief Nursing Officer at Abington Health, Lansdale Hospital.
Maurie Markman Joins as President of Cancer Treatment Centers of America's Medicine & Science Unit
May 28 14
Cancer Treatment Centers of America announced the appointment of Maurie Markman, MD, as President of the company's Medicine & Science unit, in which capacity he will be responsible for advancing the organization's overall commitment to clinical excellence, innovation, safety, and patient satisfaction. Dr. Markman served most recently as Senior Vice President of Clinical Affairs & National Director of Medical Oncology at CTCA.
In his new role, Dr. Markman will assume oversight of the CTCA national clinical team, with a focus on the application of all clinical and translational research to patient care. An expert in research on gynecologic malignancies, new drug development, and novel management strategies, Dr. Markman served in a variety of clinical leadership and academic positions at some of the country's leading cancer institutions prior to joining
CTCA in 2010, including The Cleveland Clinic, the University of Texas - MD Anderson Cancer Center, The Ohio State University, Memorial Sloan-Kettering Cancer Center, Cornell University Medical College, and the University of California San Diego School of Medicine.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|